×

Tag: SENS

Lobsters do not age like we do, perhaps we can learn to do the same.
  "Could humans become immortal?" is something we get asked quite often, and the answer depends on what exactly you mean. When it comes to immortality, what you mean is important Whether human immortality is possible greatly depends on how you define it. If you define it as living forever and being unkillable like in...
Lisa Fabiny-Kiser
We had the chance to interview Lisa Fabiny-Kiser, CEO of the well-known SENS Research Foundation, on all the various research, education, and advocacy activities that the organization is currently doing along with its plans for the future. Public opinion and the academic landscape have changed considerably since it was founded nearly 15 years ago. Would...
Martin O'Dea Interview
We recently had the opportunity to speak to Martin O’Dea about a new longevity-focused event happening in Ireland's capital city on September 18th-20th. Martin holds an MBS and is a business lecturer at Dublin Business School in Dublin, Ireland. He is also the author of Beyond the Subjectivity Trap. Martin, you are one of the...
Today we have an interview with Dr. Aubrey de Grey from the SENS Research Foundation. This interview conducted by Yuri Deigin, CEO at Youthereum Genetics, was originally published in Russian language and he has kindly translated it into English so our audience can enjoy it too. Yuri: Aubrey, thank you very much for agreeing to this...
Vitalik Buterin supports life extension.
A few days ago, LEAF representatives attended the Undoing Aging 2018 conference in Berlin, which was jointly organized by the SENS Research Foundation and the Forever Healthy Foundation. We invited one of the most professional Russian journalists writing about aging, Anna Dobryukha, to this conference, and she will write a series of articles and interviews in...
Welcome to part three and the final part of our SENS Undoing Aging 2018 interview; we have a few more scientific questions today for Aubrey and his team as well as questions about future developments and taking new therapies to market. Dr. de Grey, has your position on the relevance of telomere attrition changed since...